« Previous
Next »
Atherosclerosis Supplements
Volume 10, Issue 5
, Pages 95-101
, 29 December 2009
Fibrinogen/LDL apheresis as successful second-line treatment of sudden hearing loss: a retrospective study on 217 patients
References
- . The incidence of sudden hearing loss is greater than previously assumed . MMW. Fortschr. Med. . 2005;147:37–38
- . Studies of inner ear blood flow in animals and human beings . Otolaryngol. Head Neck Surg. . 1995;112:101–113
- . Cochlea and heart as end-organs in small vessel disease . Ann. Otol. Rhinol. Laryngol. . 1988;97:9–13
-
.
Hydroxy-methylglutarylcoenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance
.
Circulation
. 2001;103:113–118
- . Contribution of membrane cholesterol to outer hair cell lateral wall stiffness . Otolaryngol. Head Neck Surg. . 1998;119:14–20
- [Treatment of sudden hearing loss through Fibrinogen/LDL-apheresis. A prospective, randomized multicenter trial] . Z. Kardiol . 2003;92:III59–III63
- . Influence of serum lipids on auditory function . Laryngoscope . 2000;110:1736–1738
- . Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial . Lancet . 2002;360:1811–1817
- . Is there a relationship between hyper- cholesterolaemia and noise-induced hearing loss? . Acta Otolaryngol. . 1985;100:379–386
- . Distortion product oto- acoustic emissions in human hypercholesterolemia . Hear. Res. . 2001;152:139–151
- . Presbycusis study of a relatively noise-free population in the Sudan . Trans. Am. Otol. Soc. . 1962;50:135–152
- . Hypercholesterolemia and auditory dys- function. Experimental studies . Ann. Otol. Rhinol. Laryngol. . 1978;87:804–814
- . Atorvastatin slows down the deterioration of inner ear function with age in mice . Neurosci. Lett. . 2007;411:112–116
- . Extra-high frequency hearing loss and hyperlipidemia . Audiology . 1974;13:470–484
- . Hyperlipidemia and noise in the chinchilla . Acta Otolaryngol . 1985;99:516–524
- . An experimental study of auditory dys- function associated with hyperlipoproteinemia . Arch. Otorhinolaryngol. . 1986;243:242–245
- . Alterations of inner ear morphology in experimental hypercholesterolemia . Hear. Res. . 1992;61:97–105
- . The nitric oxide/cyclic GMP pathway: a potential major regulator of cochlear physiology . Hear. Res. . 1998;118:168–176
- . Whole-blood filterability in sudden deafness . Laryngoscope . 1991;101:65–67
- . Blood viscosity and plasma viscosity in patients with sudden deafness . Acta Otolaryngol. . 1994;114:601–607
- . Fibrinogen as a cardiovascular risk factor: a meta- analysis and review of the literature . Ann. Intern. Med. . 1993;118:956–963
- . Prestin is required for electromotility of the outer hair cell and for the cochlear amplifier . Nature . 2002;419:300–304
- . Prestin is the motor protein of cochlear outer hair cells . Nature . 2000;405:149–155
- Tuning of the outer hair cell motor by membrane cholesterol . J. Biol. Chem. . 2007;282:36659–36670
- . Functional expression and microdomain localization of prestin in cultured cells . Otolaryngol. Head Neck Surg. . 2007;136:434–439
- . Cholesterol interactions with phospholipids in membranes . Prog. Lipid Res. . 2002;41:66–97
- . Cholesterol effect on the dipole potential of lipid membranes . Biophys. J. . 2006;90:4060–4070
-
.
Steroids for idiopathic sudden sensori- neural hearing loss
.
Cochrane. Database. Syst. Rev.
. 2006;
CD003998
- . Natural history of sudden sensorineural hearing loss . Ann. Otol. Rhinol. Laryngol. . 1977;86:463–480
- . The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study . Arch. Otolaryngol. . 1980;106:772–776
- . A randomized, double-blind, placebo-controlled study of dextran/ pentoxifylline medication in acute acoustic trauma and sudden hearing loss . Acta Otolaryngol. . 1992;112:435–443
- Sudden sensorineural hearing loss: does application of glucocorticoids make sense? . Arch. Otolaryngol. Head Neck Surg. . 2001;127:253–258
- . Increased cerebral CO(2) reactivity after heparin-mediated extra- corporal LDL precipitation (HELP) in patients with coronary heart disease and hyperlipidemia . Stroke . 1999;30:1802–1806
- . Improved coronary vasodilatatory capacity by H.E.L.P. apheresis: comparing initial and chronic treatment . Ther. Apher. Dial. . 2006;10:510–517
- . Hearing improvement after therapy for hyperlipidemia in patients with chronic-phase sudden deafness . Ann. Otol. Rhinol. Laryngol. . 2001;110:105–108
- . H.E.L.P. apheresis therapy in the treatment of severe hyper-cholesterolemia: 10 years of clinical experience . Artif. Organs . 1996;20:303–310
- Hearing recovery in sudden deafness patients using a modified defibrinogenation therapy . Acta Otolaryngol Suppl . 1993;501:46–50
- . [Fibrinogen/LDL apheresis for treatment of sudden hearing loss: an observational study on 152 patients] . HNO . 2008;56:961–966
PII: S1567-5688(09)71820-3
doi: 10.1016/S1567-5688(09)71820-3
© 2009 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Atherosclerosis Supplements
Volume 10, Issue 5
, Pages 95-101
, 29 December 2009
